|
|
|
FDA Home | Search FDA Site
| A-Z Index | Contact
FDA
1. Name the one risk in the list below that doesn't increase with the use of estrogen or estrogen-with-progestin products in post-menopausal women. (a.) bone fracture
2. Why was a study of estrogen-with-progestin treatments in 16,000 postmenopausal women stopped in 2002? (b.) The study determined that risks of the drugs outweigh the benefits.
3. Proteomics is: (b.) the study of proteins in living cells that may lead to an early detection tool for ovarian cancer.
4. At one time, prescription drug makers promoted their products exclusively to: (c.) health care professionals
5. In what year was smallpox declared eradicated globally? (c.) 1980
6. Approximately how many people in the United States have asthma? (c.) 15 million
7. About how many deaths each year are caused by asthma? (d.) 4,500
8. According to the American Association of Blood Banks, how many units of red blood cells are needed daily in the United States? (d.) more than 30,000
9. In a 2001 survey, about how many youths aged 12 to 17 reported using prescription medicines non-medically at least once in their lifetimes? (c.) 3 million
8 to 9 points: Excellent! Go to the head of the class.
5 to 7 points: Not too bad. You can skip cleaning the chalkboard erasers today.
Below 5 points: Oops! Stay after school and reread the appropriate chapters.